Nephrologists treating children with kidney disease or metabolic syndrome have different challenges and opportunities than when treating adults, according to Tammy Brady, MD, PhD, medical director of the Pediatric Hypertension Program and associate professor of pediatrics at Johns Hopkins University.
Nephrologists treating children with kidney disease or metabolic syndrome have different challenges and opportunities than when treating adults, according to Tammy Brady, MD, PhD, medical director of the Pediatric Hypertension Program and associate professor of pediatrics at Johns Hopkins University.
Transcript
What are the special considerations when treating children with kidney disease or metabolic syndrome as opposed to adults?
With pediatrics, you’re dealing with a family unit in addition to your pediatric patient, so you not only need to educate and inform the child or adolescent, but you need to educate and inform the family members who are caring for that patient of yours. Then in regards to metabolic syndrome, the specific components of metabolic syndrome, namely obesity, hypertension, insulin resistance, and dyslipidemia, they’re all related to learned health behaviors.
So in peds, or in pediatrics, we have a great opportunity to really get in there early and make a real difference helping them to unlearn some of those unhealthy behaviors and relearn more ideal health behaviors. But also on the other side, you also have that family unit, and some of those behaviors were learned from the adults in their lives, and so you need to work hard to get buy-in from those individuals, because without that buy-in, you’re going to have a lot of challenges being successful with implementing heart-healthy behaviors.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More